Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Programs Opioids Clinical Primer Resources Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Evidence, Guidelines and Recommendations

The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario. Provided by the Centre for Addiction and Mental Health (CAMH) and the College of Physicians and Surgeons of Ontario (CPSO)

Details

Related Resources

Health Quality Ontario Standards: Opioid Use Disorder (Opioid Addiction)

This quality standard includes: quality statements, patient reference guide, recommendations for adoption and a getting started guide.

Visit

Learn more

Opioid Wisely

Find 15 specialty-specific recommendations for when the use of opioids should not be first line therapy and information resources to help patients have informed conversations with their clinicians about safe options for managing pain.

Visit

Learn more

Slow-release oral morphine as opioid agonist therapy: Plain language summary

A summary of the recommendations, intended for patients interested in learning about SROM as OAT.

Learn more